Betrixaban is a broad anti-virus inhibitor by activating innate immunity

The innate immune system serves as the first line of defense against viral infections. Type I interferon (IFN-I) signaling, in particular, plays a crucial role in mediating antiviral immunity. Here, we identify Betrixaban (BT), a novel small-molecule compound that activates innate immune responses,...

Full description

Saved in:
Bibliographic Details
Main Authors: Shiyu Hu, Yang Zhao, Xingyu Chen, Haocheng Wang, Wenjun Hu, Rong Huang, Jian Yang, Chenxi Niu, Xuefei Guo, Fuping You
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1603530/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849231563880923136
author Shiyu Hu
Yang Zhao
Xingyu Chen
Haocheng Wang
Wenjun Hu
Rong Huang
Jian Yang
Chenxi Niu
Xuefei Guo
Fuping You
author_facet Shiyu Hu
Yang Zhao
Xingyu Chen
Haocheng Wang
Wenjun Hu
Rong Huang
Jian Yang
Chenxi Niu
Xuefei Guo
Fuping You
author_sort Shiyu Hu
collection DOAJ
description The innate immune system serves as the first line of defense against viral infections. Type I interferon (IFN-I) signaling, in particular, plays a crucial role in mediating antiviral immunity. Here, we identify Betrixaban (BT), a novel small-molecule compound that activates innate immune responses, leading to broad-spectrum antiviral effects. BT induces IFN-β production and upregulates interferon-stimulated genes (ISGs), effectively suppressing the replication of multiple viruses, including vesicular stomatitis virus (VSV), herpes simplex virus type 1 (HSV-1), murine hepatitis virus strain A59 (MHV-A59), encephalomyocarditis virus (EMCV), and influenza A virus (IAV). BT’s antiviral activity relies on innate immune activation, with IRF3 playing a key role. The antiviral effect was significantly reduced upon loss of ISGs induction, including Mx1 and Mx2. In vivo, BT treatment markedly induced IFNB1 expression across multiple mouse tissues and significantly inhibited viral replication in VSV-infected wild-type mice, confirming the essential role of innate antiviral immune activation. These findings establish BT as a potent stimulator of the innate immune system, demonstrating broad-spectrum antiviral potential and highlighting its promise as a therapeutic agent.
format Article
id doaj-art-6412a19c47b44a279871cf583e0c340f
institution Kabale University
issn 2235-2988
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-6412a19c47b44a279871cf583e0c340f2025-08-21T05:27:23ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-08-011510.3389/fcimb.2025.16035301603530Betrixaban is a broad anti-virus inhibitor by activating innate immunityShiyu Hu0Yang Zhao1Xingyu Chen2Haocheng Wang3Wenjun Hu4Rong Huang5Jian Yang6Chenxi Niu7Xuefei Guo8Fuping You9Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, ChinaInstitute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, ChinaInstitute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, ChinaInstitute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, ChinaDepartment of Orthopedics and Traumatology, Nanchong Hospital of Traditional Chinese Medicine, Nanchong, ChinaInstitute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, ChinaInstitute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, ChinaDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, ChinaInstitute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, ChinaInstitute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Peking University Health Science Center, Beijing, ChinaThe innate immune system serves as the first line of defense against viral infections. Type I interferon (IFN-I) signaling, in particular, plays a crucial role in mediating antiviral immunity. Here, we identify Betrixaban (BT), a novel small-molecule compound that activates innate immune responses, leading to broad-spectrum antiviral effects. BT induces IFN-β production and upregulates interferon-stimulated genes (ISGs), effectively suppressing the replication of multiple viruses, including vesicular stomatitis virus (VSV), herpes simplex virus type 1 (HSV-1), murine hepatitis virus strain A59 (MHV-A59), encephalomyocarditis virus (EMCV), and influenza A virus (IAV). BT’s antiviral activity relies on innate immune activation, with IRF3 playing a key role. The antiviral effect was significantly reduced upon loss of ISGs induction, including Mx1 and Mx2. In vivo, BT treatment markedly induced IFNB1 expression across multiple mouse tissues and significantly inhibited viral replication in VSV-infected wild-type mice, confirming the essential role of innate antiviral immune activation. These findings establish BT as a potent stimulator of the innate immune system, demonstrating broad-spectrum antiviral potential and highlighting its promise as a therapeutic agent.https://www.frontiersin.org/articles/10.3389/fcimb.2025.1603530/fullbroad-spectrum antiviralBetrixabanFXainnate immunityVSV
spellingShingle Shiyu Hu
Yang Zhao
Xingyu Chen
Haocheng Wang
Wenjun Hu
Rong Huang
Jian Yang
Chenxi Niu
Xuefei Guo
Fuping You
Betrixaban is a broad anti-virus inhibitor by activating innate immunity
Frontiers in Cellular and Infection Microbiology
broad-spectrum antiviral
Betrixaban
FXa
innate immunity
VSV
title Betrixaban is a broad anti-virus inhibitor by activating innate immunity
title_full Betrixaban is a broad anti-virus inhibitor by activating innate immunity
title_fullStr Betrixaban is a broad anti-virus inhibitor by activating innate immunity
title_full_unstemmed Betrixaban is a broad anti-virus inhibitor by activating innate immunity
title_short Betrixaban is a broad anti-virus inhibitor by activating innate immunity
title_sort betrixaban is a broad anti virus inhibitor by activating innate immunity
topic broad-spectrum antiviral
Betrixaban
FXa
innate immunity
VSV
url https://www.frontiersin.org/articles/10.3389/fcimb.2025.1603530/full
work_keys_str_mv AT shiyuhu betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT yangzhao betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT xingyuchen betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT haochengwang betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT wenjunhu betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT ronghuang betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT jianyang betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT chenxiniu betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT xuefeiguo betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity
AT fupingyou betrixabanisabroadantivirusinhibitorbyactivatinginnateimmunity